Centrepoint Alliance (ASX:CAF) Research & Development: A$0.00 Mil (TTM As of Dec. 2025)


ASX:CAF Centrepoint Alliance Ltd ASX:CAF
39 GF Score
Price A$0.37
GF Value A$0.32
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Centrepoint Alliance Research & Development?

Centrepoint Alliance ASX:CAF -1.33% 39 Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:CAF with a GF Score™ of 39/100 and a GF Value™ of A$0.32 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Centrepoint Alliance's Research & Development for the six months ended in Dec. 2025 was A$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

Centrepoint Alliance  (ASX:CAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Centrepoint Alliance Research & Development Related Terms

Centrepoint Alliance Research & Development Historical Data

* Premium members only.

The historical data trend for Centrepoint Alliance's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Centrepoint Alliance Research & Development Chart

Centrepoint Alliance Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Centrepoint Alliance Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:CAF
39GF Score
Centrepoint Alliance Ltd ASX:CAF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Centrepoint Alliance Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of A$0.00 Mil mean?
Centrepoint Alliance (ASX:CAF) has a Research & Development of A$0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Centrepoint Alliance and its competitors.
Is Centrepoint Alliance's Research & Development too high?
Centrepoint Alliance's current Research & Development is A$0.00 Mil. Overall, Centrepoint Alliance has a GF Score™ of 39/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Centrepoint Alliance's Research & Development compare to BLK and BX?
Centrepoint Alliance's Research & Development of A$0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Centrepoint Alliance and its competitors. Centrepoint Alliance's current Research & Development is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Centrepoint Alliance stock overvalued right now?
Based on GuruFocus' analysis, Centrepoint Alliance (ASX:CAF) is currently considered Modestly Overvalued. The stock's GF Value™ is A$0.32, compared to a current price of A$0.37 — trading 15.6% above its estimated fair value. The current Research & Development is A$0.00 Mil. Centrepoint Alliance's overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Centrepoint Alliance (ASX:CAF), the current Research & Development is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Centrepoint Alliance (ASX:CAF) Overvalued in 2026?

Based on GuruFocus' analysis, Centrepoint Alliance stock appears to be overvalued. The current stock price of A$0.37 is trading 15.6% above its estimated GF Value™ of A$0.32. GuruFocus considers Centrepoint Alliance to be Modestly Overvalued.

Key valuation signals for ASX:CAF:

  • Research & Development: A$0.00 Mil
  • GF Value™: A$0.32 vs. price of A$0.37 (15.6% above fair value)
  • GF Score™: 39/100 with 3 warning signs

No single metric tells the full story. See the ASX:CAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Centrepoint Alliance Business Description

Address 309315 George Street, Level 8, Sydney, NSW, AUS, 2000
Centrepoint Alliance Ltd is a community of financial advisers. It provides technology, services, education, and on-the-ground training to its clients. The company's reportable segments are Licensee and Advice Services which generates maximum revenue for the company provides Australian Financial Services Licence-related services to financial advisers and its clients and mortgage broking services; Funds Management and Administration segment provides investor-directed portfolio services and investment management services to financial advisers and their clients; Consulting services segment represents the business that provides consulting to both self-licensed advisers and licensees.
39GF Score

Get the complete analysis for ASX:CAF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.37
Price
A$0.32
GF Value